The American Journal of Medicine
Volume 122, Issue 8 , Pages 778.e9-778.e15 , August 2009

Depression and Health-Related Quality of Life in Chronic Obstructive Pulmonary Disease

  • Theodore A. Omachi, MD, MBA

      Affiliations

    • Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco
    • Corresponding Author InformationRequests for reprints should be addressed to Theodore A. Omachi, MD, MBA, Department of Medicine, University of California, San Francisco, Box 0111, 505 Parnassus Avenue, San Francisco, CA 94143-0111
    • ,
  • Patricia P. Katz, PhD

      Affiliations

    • Institute for Health Policy Studies, University of California, San Francisco
    • ,
  • Edward H. Yelin, PhD

      Affiliations

    • Institute for Health Policy Studies, University of California, San Francisco
    • Division of Rheumatology, Department of Medicine, University of California, San Francisco
    • ,
  • Steven E. Gregorich, PhD

      Affiliations

    • Division of General Internal Medicine, Department of Medicine, University of California, San Francisco
    • ,
  • Carlos Iribarren, MD, MPH, PhD

      Affiliations

    • Division of Research, Kaiser Permanente, Oakland, Calif
    • ,
  • Paul D. Blanc, MD, MSPH

      Affiliations

    • Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco
    • Division of Occupational and Environmental Medicine, Department of Medicine, University of California, San Francisco
    • ,
  • Mark D. Eisner, MD, MPH

      Affiliations

    • Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco
    • Division of Occupational and Environmental Medicine, Department of Medicine, University of California, San Francisco

References 

  1. Ruo B, Rumsfeld JS, Hlatky MA, et al. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA. 2003;290:215–221
  2. Wijkstra PJ, Ten Vergert EM, van Altena R, et al. Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease. Thorax. 1995;50:824–828
  3. Goldstein RS, Gort EH, Stubbing D, et al. Randomised controlled trial of respiratory rehabilitation. Lancet. 1994;344(8934):1394–1397
  4. Lacasse Y, Martin S, Lasserson TJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease (A Cochrane systematic review). Eura Medicophys. 2007;43:475–485
  5. Norwood R, Balkissoon R. Current perspectives on management of co-morbid depression in COPD. COPD. 2005;2:185–193
  6. Felker B, Katon W, Hedrick SC, et al. The association between depressive symptoms and health status in patients with chronic pulmonary disease. Gen Hosp Psychiatry. 2001;23:56–61
  7. Kim HF, Kunik ME, Molinari VA, et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics. 2000;41:465–471
  8. Wamboldt FS. Anxiety and depression in COPD: a call (and need) for further research. COPD. 2005;2:199–201
  9. van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax. 1999;54:688–692
  10. McSweeny AJ, Grant I, Heaton RK, et al. Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med. 1982;142:473–478
  11. van Manen JG, Bindels PJ, Dekker FW, et al. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax. 2002;57:412–416
  12. Engstrom CP, Persson LO, Larsson S, et al. Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking: a descriptive and comparative study. Thorax. 1996;51:825–830
  13. Isoaho R, Keistinen T, Laippala P, Kivela SL. Chronic obstructive pulmonary disease and symptoms related to depression in elderly persons. Psychol Rep. 1995;76:287–297
  14. Eisner MD, Iribarren C, Yelin EH, et al. Pulmonary function and the risk of functional limitation in chronic obstructive pulmonary disease. Am J Epidemiol. 2008;167:1090–1101
  15. Sidney S, Sorel M, Quesenberry CP, et al. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005;128(4):2068–2075
  16. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary). Am J Respir Crit Care Med. 2001;163:1256–1276
  17. Rule BG, Harvey HZ, Dobbs AR. Reliability of the Geriatric Depression Scale for younger adults. Clin Gerontol. 1989;9:37–43
  18. Mancuso CA, Peterson MG, Charlson ME. Effects of depressive symptoms on health-related quality of life in asthma patients. J Gen Intern Med. 2000;15:301–310
  19. Ferraro FR, Chelminski I. Preliminary normative data on the Geriatric Depression Scale-Short Form (GDS-SF) in a young adult sample. J Clin Psychol. 1996;52:443–447
  20. Gerety MB, Williams JW, Mulrow CD, et al. Performance of case-finding tools for depression in the nursing home: influence of clinical and functional characteristics and selection of optimal threshold scores. J Am Geriatr Soc. 1994;42:1103–1109
  21. Whooley MA, Browner WS. Association between depressive symptoms and mortality in older women (Study of Osteoporotic Fractures Research Group). Arch Intern Med. 1998;158:2129–2135
  22. Chen H, Eisner MD, Katz PP, et al. Measuring disease-specific quality of life in obstructive airway disease: validation of a modified version of the airways questionnaire 20. Chest. 2006;129:1644–1652
  23. Hajiro T, Nishimura K, Jones PW, et al. A novel, short, and simple questionnaire to measure health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:1874–1878
  24. Alemayehu B, Aubert RE, Feifer RA, Paul LD. Comparative analysis of two quality-of-life instruments for patients with chronic obstructive pulmonary disease. Value Health. 2002;5:437–442
  25. Benzo R, Flume PA, Turner D, Tempest M. Effect of pulmonary rehabilitation on quality of life in patients with COPD: the use of SF-36 summary scores as outcomes measures. J Cardiopulm Rehabil. 2000;20:231–234
  26. Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–233
  27. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152:1107–1136
  28. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117
  29. Fishman AP. Pulmonary rehabilitation research. Am J Respir Crit Care Med. 1994;149(3 Pt 1):825–833
  30. Eisner MD, Trupin L, Katz PP, et al. Development and validation of a survey-based COPD severity score. Chest. 2005;127:1890–1897
  31. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–1012
  32. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd edn.. Hoboken, NJ: John Wiley & Sons, Inc; 2000;
  33. Bijl RV, de Graaf R, Hiripi E, et al. The prevalence of treated and untreated mental disorders in five countries. Health Aff (Millwood). 2003;22:122–133
  34. Weissman MM, Bland RC, Canino GJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996;276:293–299
  35. Wagena EJ, Kant I, van Amelsvoort LG, et al. Risk of depression and anxiety in employees with chronic bronchitis: the modifying effect of cigarette smoking. Psychosom Med. 2004;66:729–734
  36. Kendler KS, Neale MC, MacLean CJ, et al. Smoking and major depression (A causal analysis). Arch Gen Psychiatry. 1993;50:36–43
  37. Wagena EJ, Huibers MJ, van Schayck CP. Antidepressants in the treatment of patients with COPD: possible associations between smoking cigarettes, COPD and depression. Thorax. 2001;56:587–588
  38. Simon GE, Von Korff M, Lin E. Clinical and functional outcomes of depression treatment in patients with and without chronic medical illness. Psychol Med. 2005;35:271–279
  39. Borson S, McDonald GJ, Gayle T, et al. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics. 1992;33:190–201
  40. Coventry PA, Hind D. Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: Systematic review and meta-analysis. J Psychosom Res. 2007;63:551–565
  41. Withers NJ, Rudkin ST, White RJ. Anxiety and depression in severe chronic obstructive pulmonary disease: the effects of pulmonary rehabilitation. J Cardiopulm Rehabil. 1999;19:362–365
  42. Paz-Diaz H, Montes de Oca M, Lopez JM, Celli BR. Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil. 2007;86:30–36
  43. Kunik ME, Braun U, Stanley MA, et al. One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychol Med. 2001;31:717–723
  44. Eisner MD, Balmes J, Katz PP, et al. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health. 2005;4:7
  45. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance—United States, 1971-2000. MMWR Surveill Summ. 2002;51:1–16
  46. Karter AJ, Ferrara A, Liu JY, et al. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002;287:2519–2527
  47. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82:703–710
  48. Anderson IM, Nutt DJ, Deakin JF. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines (British Association for Psychopharmacology). J Psychopharmacol. 2000;14:3–20

 Funding: Dr. Omachi was supported by the Agency for Healthcare Research and Quality, Grant number F32 HS017664. Dr. Eisner was supported by R01HL077618 from the National Heart, Lung, and Blood Institute, National Institutes of Health, and UCSF Bland Lane FAMRI Center of Excellence on Secondhand Smoke CoE2007.

 Conflict of Interest: None.

 Authorship: All authors had access to the data and a role in writing the manuscript.

PII: S0002-9343(09)00345-3

doi: 10.1016/j.amjmed.2009.01.036

The American Journal of Medicine
Volume 122, Issue 8 , Pages 778.e9-778.e15 , August 2009

Article Tools